DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 209777
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
The generic ingredient in ROXYBOND is oxycodone hydrochloride. There are nineteen drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the oxycodone hydrochloride profile page.
Summary for 209777
Tradename: | ROXYBOND |
Applicant: | Inspirion Delivery |
Ingredient: | oxycodone hydrochloride |
Patents: | 2 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
Approval Date: | Apr 20, 2017 | TE: | RLD: | No | |||||
Regulatory Exclusivity Expiration: | Apr 20, 2020 | ||||||||
Regulatory Exclusivity Use: | NEW PRODUCT | ||||||||
Patent: | Start Trial | Patent Expiration: | Aug 12, 2028 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patent: | Start Trial | Patent Expiration: | Aug 12, 2028 | Product Flag? | Y | Substance Flag? | Delist Request? |
Complete Access Available with Subscription